Furthermore, since IL‐17B/IL‐17RB signaling activates NF‐κB in human breast cancer (Huang et al, 2014), NF‐κB nuclear translocation can serve as the measurement for the consequence of Il‐17rb induction. The gene discussed is NFKB1; the disease is breast carcinoma.